Navigation Links
LeMaitre Vascular Reports Q1 2008 Revenue of $11.8 Million, a 20% Increase
Date:4/30/2008

cacy or may not be accepted by the market for other reasons; the Company's ability to expand its product offerings through internal development or acquisition; disruption at any of the Company's manufacturing facilities; the general uncertainty related to seeking regulatory approvals for the Company's products, particularly in the United States; potential claims of third parties that the Company's products infringe their intellectual property rights; and the risks and uncertainties included under the heading "Risk Factors" in our most recent Annual Report on Form 10-K, as updated by any subsequent filings with the SEC, all of which are available on the Company's investor relations website at http://www.lemaitre.com and on the SEC's website at http://www.sec.gov. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. The Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

Financial Statements

LEMAITRE VASCULAR, INC (NASDAQ: LMAT)

CONDENSED CONSOLIDATED BALANCE SHEETS

(amounts in thousands)

March 31, 2008 December 31, 2007

(unaudited)

Assets

Current assets:

Cash and cash equivalents $5,444 $6,691

Marketable securities 12,358 16,198

Accounts receivable, net 7,166 7
'/>"/>

SOURCE LeMaitre Vascular, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. LeMaitre Vascular to Participate in 28th Annual Cowen and Company Health Care Conference
2. LeMaitre Vascular Acquires Biomateriali, a Vascular Graft Manufacturer
3. LeMaitre Vascular Appoints Russell D. Hays to Its Board of Directors
4. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
5. CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
6. CardioVascular BioTherapeutics, Inc. Announces Update on Timing of Form 10-K Filing
7. Angiotech elects to suspend Vascular Wrap(TM) pivotal clinical trials
8. ES Vascular Receives CE Mark for its First Aortic Stapler for End-to-End Anastomosis Between Synthetic Grafts and Aorta During Open Repair of Aortic Aneurysmal and Occlusive Disease
9. BRISTOL-MYERS SQUIBB SELECTS ISIS DRUG TARGETING PCSK9 AS DEVELOPMENT CANDIDATE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE
10. Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over
11. Boston Scientific Announces Sale of TriVascular Endovascular Aortic Repair Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Convey Computer , the leader in ... State University won first place in the 2014 ... the team’s solution achieved the highest overall performance in ... place finisher. , Experts from all segments of the ... challenge, using a variety of design tools, hardware and ...
(Date:10/20/2014)... , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Horovitz , Ph.D., from its board of directors effective on ... August 2003, and served as its chairman from June 2006 ... the Nominating and Corporate Governance and Audit Committees of the ... than a decade of dedicated service to GenVec, and its ...
(Date:10/20/2014)... 20, 2014 Local veterinary surgeon, Dr. ... investigational study of donor stem cells for dogs with ... therapy and has performed clinical stem cell therapy for ... to determine if a single injection of donor stem ... help reduce pain and inflammation in the treated joints. ...
(Date:10/19/2014)... (PRWEB) October 19, 2014 The ... bromine market in Asia-Pacific with analysis and forecast ... the Asia Pacific Bromine Market report, to get ... also provides a glimpse of the segmentation in ... various tables and figures. , http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html ...
Breaking Biology Technology:Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3Zola P. Horovitz To Retire From GenVec Board 2Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3
... Families Can Invest Simultaneously in Future Healthcare and ... Inc., one of the world,s largest and most ... stem cell innovation, recently,renewed their agreement as an ... college funding contributions in America. Since,2004, Cryo-Cell has ...
... Sheets: CGCP), a leading developer of surgical products,used in ... financial results for its third quarter ended September 30, ... the third quarter of 2008 totaled $2,618,000, a 25% ... The lower revenue in,the current year quarter is primarily ...
... (Nasdaq: MEMY ), today reported its financial ... "Our results reflect continued clinical progress on ... into innovative therapies,",stated Vaughn M. Kailian, President and ... agreement with Roche to enhance our,ongoing Phase 2 ...
Cached Biology Technology:Cryo-Cell Renews Upromise Industry-Exclusive Agreement 2Cryo-Cell Renews Upromise Industry-Exclusive Agreement 3Cryo-Cell Renews Upromise Industry-Exclusive Agreement 4Cardiogenesis Reports Third Quarter 2008 Results 2Cardiogenesis Reports Third Quarter 2008 Results 3Cardiogenesis Reports Third Quarter 2008 Results 4Cardiogenesis Reports Third Quarter 2008 Results 5Cardiogenesis Reports Third Quarter 2008 Results 6Cardiogenesis Reports Third Quarter 2008 Results 7Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results 2Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results 3Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results 4Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results 5Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results 6Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results 7Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results 8
(Date:10/14/2014)... discriminating thieves, prostate cancer tumors scavenge and hoard copper ... such avarice may be a fatal weakness. , ... kill prostate cancer cells by delivering a trove of ... diseased cells brimming with the mineral, leaving non-cancer cells ... already commercially available for other uses, could soon be ...
(Date:10/14/2014)... of the planet,s leading questions is how to produce ... variable climate. The Food and Agriculture Organization of the ... over the next 40 years to feed a growing ... the necessary rise in food production. Plants—grains, cereals, ... supporting livestock. Current research must tap into our ...
(Date:10/14/2014)... led by researchers at the University of Massachusetts ... Miller School of Medicine (UMMSM) have identified what ... (manic depressive) disorder, a breakthrough that could lead ... as well as depression and other related mood ... week in Nature Molecular Psychiatry , show ...
Breaking Biology News(10 mins):Prostate cancer's penchant for copper may be a fatal flaw 2Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3Rare genetic disease protects against bipolar disorder 2Rare genetic disease protects against bipolar disorder 3
... fracture) in women is highly recognized by the public. Less appreciated ... two million males have been diagnosed with osteoporosis and another three ... are thought to be major factors behind bone fractures in both ... low levels of the testosterone are known to be at risk. ...
... HARBOR, N.Y. In 1911, the influential geneticist Charles ... his ideas of how genetics would improve society in the ... foundation for the widespread eugenics movement in the United States. ... the 20th century have long been rejected, many of the ...
... University of Minnesota School of Public Health researchers have ... are less likely to engage in healthy activities such ... meals. They also consumed larger quantities of sweetened beverages ... and read or studied less than teens without TVs ...
Cached Biology News:Testosterone replacement theraphy beneficial in men 60 and older 2Testosterone replacement theraphy beneficial in men 60 and older 3Reflecting on the social implications of human genetics research -- past, present and future 2U of M research finds teens who have TV in their bedroom are less likely to engage in healthy habits 2
Please email us with project details and we will respond within 24 hours to your query!...
Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, glycerol solution....
Request Info...
Request Info...
Biology Products: